company background image
AIO logo

Abiomed DB:AIO Stock Report

Last Price

€357.40

Market Cap

€16.2b

7D

1.2%

1Y

15.5%

Updated

24 Dec, 2022

Data

Company Financials +

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

AIO Stock Overview

Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart.

AIO fundamental analysis
Snowflake Score
Valuation0/6
Future Growth1/6
Past Performance4/6
Financial Health6/6
Dividends0/6

Abiomed, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Abiomed
Historical stock prices
Current Share PriceUS$357.40
52 Week HighUS$382.40
52 Week LowUS$213.00
Beta1.4
1 Month Change-0.94%
3 Month Change43.13%
1 Year Change15.51%
3 Year Change135.60%
5 Year Change128.70%
Change since IPO9,268.53%

Recent News & Updates

Recent updates

Shareholder Returns

AIODE Medical EquipmentDE Market
7D1.2%-1.0%1.4%
1Y15.5%4.5%7.5%

Return vs Industry: AIO exceeded the German Medical Equipment industry which returned -32.2% over the past year.

Return vs Market: AIO exceeded the German Market which returned -21.5% over the past year.

Price Volatility

Is AIO's price volatile compared to industry and market?
AIO volatility
AIO Average Weekly Movement14.7%
Medical Equipment Industry Average Movement4.7%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.2%
10% least volatile stocks in DE Market2.4%

Stable Share Price: AIO's share price has been volatile over the past 3 months.

Volatility Over Time: AIO's weekly volatility has increased from 9% to 15% over the past year.

About the Company

FoundedEmployeesCEOWebsite
19812,003Mike Minoguehttps://www.abiomed.com

Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by interventional cardiologists to support patients in the cath lab, as well as by cardiac surgeons in the heart surgery suite.

Abiomed, Inc. Fundamentals Summary

How do Abiomed's earnings and revenue compare to its market cap?
AIO fundamental statistics
Market cap€16.19b
Earnings (TTM)€251.27m
Revenue (TTM)€1.01b

64.4x

P/E Ratio

16.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AIO income statement (TTM)
RevenueUS$1.07b
Cost of RevenueUS$200.59m
Gross ProfitUS$873.51m
Other ExpensesUS$606.74m
EarningsUS$266.76m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)5.91
Gross Margin81.32%
Net Profit Margin24.84%
Debt/Equity Ratio0%

How did AIO perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.